Cargando…
Graft versus host disease: New insights into A(2A) receptor agonist therapy
Allogeneic transplantation can cure many disorders, including sickle cell disease, chronic granulomatous disease (CGD), severe combined immunodeficiency (SCID) and many types of cancers. However, there are several associated risks that can result in severe immunological reactions and, in some cases,...
Autores principales: | Jones, Karlie R., Kang, Elizabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334952/ https://www.ncbi.nlm.nih.gov/pubmed/25709759 http://dx.doi.org/10.1016/j.csbj.2014.12.003 |
Ejemplares similares
-
COVID-19 and graft-versus-host disease: a tale of two diseases (and why age matters)
por: Murphy, George F.
Publicado: (2021) -
Biomarkers in acute graft-versus-host disease: new insights
por: Srinagesh, Hrishikesh K., et al.
Publicado: (2019) -
New Insight for the Diagnosis of Gastrointestinal Acute Graft-versus-Host Disease
por: Malard, Florent, et al.
Publicado: (2014) -
New insights into the basic biology of acute graft-versus-host-disease
por: Li, Alicia, et al.
Publicado: (2020) -
Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
por: Perretti, Mauro, et al.
Publicado: (2020)